Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
Division of Blood Diseases and Resources (DBDR)
93.839
To foster research and research training on the pathophysiology, diagnosis, treatment, and prevention of non-neoplastic blood diseases, including anemias, sickle cell disease, thalassemia; biology of red blood cells, white blood cells, and platelets, hematopoietic stem cells and the bone marrow niche, hemophilia and other abnormalities of hemostasis and thrombosis.. Funding encompasses a broad spectrum of hematology research, ranging from hematopoietic stem cell biology to drug development to treat blood diseases, ensuring the adequacy and safety of the nation's blood supply.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
The estimates for fiscal year 2016 are 629 research grants and 98 National Research Service Awards. 649 research grants and 87 National Research Service Awards.
The estimates for fiscal year 2019 are 755 research grants and 109 National Research Service Awards.
The estimates for fiscal year 2024 are 712 research grants and 95 National Research Service Awards.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.
